Molecular structure of Darolutamide, CAS Number: 1297538-32-9
Darolutamide (CAS 1297538-32-9)
CAS Number:
1297538-32-9
Molecular Weight:
398.85
Molecular Formula:
C19H19ClN6O2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Darolutamide (CAS 1297538-32-9) References
- Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer. | Fizazi, K., et al. 2019. N Engl J Med. 380: 1235-1246. PMID: 30763142
- Drug-Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies. | Zurth, C., et al. 2019. Eur J Drug Metab Pharmacokinet. 44: 747-759. PMID: 31571146
- Darolutamide: First Approval. | Markham, A. and Duggan, S. 2019. Drugs. 79: 1813-1818. PMID: 31605368
- Darolutamide for treatment of castration-resistant prostate cancer. | Rhea, LP., et al. 2020. Drugs Today (Barc). 56: 185-193. PMID: 32282865
- Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide. | Fizazi, K., et al. 2020. N Engl J Med. 383: 1040-1049. PMID: 32905676
- Darolutamide in hormone-sensitive and castration-resistant prostate cancer. | Palmieri, VE., et al. 2021. Expert Rev Clin Pharmacol. 14: 535-544. PMID: 33685318
- Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis. | Wenzel, M., et al. 2022. Prostate Cancer Prostatic Dis. 25: 139-148. PMID: 34054128
- Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer. | Smith, MR., et al. 2022. N Engl J Med. 386: 1132-1142. PMID: 35179323
- Apalutamide, Darolutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC): A Critical Review. | Cattrini, C., et al. 2022. Cancers (Basel). 14: PMID: 35406564
- Darolutamide: A Review in Metastatic Hormone-Sensitive Prostate Cancer. | Lee, A. 2023. Target Oncol. 18: 793-800. PMID: 37542594
Inhibitor of:
9230110F15Rik, Androgen Receptor, AR, ARA54, ARL13B, ARL3, Glycodelin, Kap, Pma, Prostate Tumor Marker, PSGR, SMR2, SMR3A, SPANX-N3, and TCP-11.Activator of:
MFAP1A.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Darolutamide, 10 mg | sc-507537 | 10 mg | $250.00 |